DEBORAH BULLARD: Open Payments
NPI 1801985205 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 35 payments from 11 companies in 2025. Trend: 2023 $2,052 · 2024 $1,700 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $142 |
| Alkermes, Inc. | 5 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 4 | $64 |
| ABBVIE INC. | 2 | $48 |
| Tris Pharma Inc | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: COBENFY, ARISTADA, CAPLYTA, Jornay PM, HETLIOZ, VRAYLAR, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
